This page is part of the US Drug Formulary (v2.0.1: STU 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Page standards status: Trial-use |
Generated Narrative: GraphDefinition
Resource GraphDefinition "FormularyGraphDefinition"
Profile: Formulary Bulk Data Graph Definition
wg: phx
Standards Status: trial-use
version: 2.0.1
name: FormularyGraphDefinition
status: active
date: 2023-11-03 19:55:21-0700
publisher: HL7 International / Pharmacy
contact: HL7 International / Pharmacy: http://www.hl7.org/Special/committees/medication,pharmacy@lists.HL7.org
jurisdiction: United States of America (ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code#US)
start: InsurancePlan
profile: Formulary
link
target
type: Basic
params: formulary={ref}
profile: Formulary Item
link
path: Basic.subject
target